YAVUZ, A. N. Et Al. 2022. Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model. JOURNAL OF RESEARCH IN PHARMACY , vol.26, no.2 , 298-310.

YAVUZ, A. N., Yıldız, S., KELEŞ, R., ÇAM, M. E., & KABASAKAL, L., (2022). Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model. JOURNAL OF RESEARCH IN PHARMACY , vol.26, no.2, 298-310.

YAVUZ, AYŞE Et Al. "Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model," JOURNAL OF RESEARCH IN PHARMACY , vol.26, no.2, 298-310, 2022

YAVUZ, AYŞE N. Et Al. "Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model." JOURNAL OF RESEARCH IN PHARMACY , vol.26, no.2, pp.298-310, 2022

YAVUZ, A. N. Et Al. (2022) . "Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model." JOURNAL OF RESEARCH IN PHARMACY , vol.26, no.2, pp.298-310.

@article{article, author={AYŞE NUR YAVUZ Et Al. }, title={Sodium-glucose co-transporter inhibitor dapagliflozin attenuates cognitive deficits in sporadic Alzheimer’s rat model}, journal={JOURNAL OF RESEARCH IN PHARMACY}, year=2022, pages={298-310} }